CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Qualia Mind +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04389723
NCT04389723N/ACompleted
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety and Efficacy of Qualia Mind on Cognition in a Healthy Population

Neurohacker Collective·interventional·Posted May 15, 2020·Updated Oct 9, 2020

In Brief

A clinical study evaluating Qualia Mind and Placebo for Healthy and Cognitive Function. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, placebo-controlled, crossover study designed to investigate the safety and efficacy of Qualia Mind on cognition in a healthy adult population between ages of 18 and 75 years. Qualia Mind is a nootropic supplement containing a complex mixture of vitamins, minerals, amino acids, choline donors, and herbal ingredients. These components have been demonstrated to exert their cognitive effects through distinct mechanisms of action involving cholinergic, glutamatergic, and dopaminergic receptor signalling; neuroplasticity; and modulation of cell membrane structure and metabolism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Cognitive Function
CountriesUnited States
CollaboratorsKGK Science Inc.

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 15, 2020
Enrollment StartMay 12, 2020
Primary CompletionSep 15, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.1 years ago

Interventions

Qualia Minddietary

Multi-ingredient Dietary supplement

Placebodietary

Multi-ingredient Placebo